Crucible · Firm report card
Rise Therapeutics, LLC
MD · SBIR awardee across 1 federal program (HHS/NIH), first award 2018.
18SBIR awards
$23MSBIR $
8 → 10Phase I → II
$0Follow-on federal $
0Follow-on contracts
SBIR awards by program
| Program | Awards | SBIR $ | Phase I | Phase II |
|---|---|---|---|---|
| HHS/NIH | 18 | $23M | 8 | 10 |
Mission areas
Open the interactive profile of Rise Therapeutics, LLC →Full award history, follow-on contract detail, and cross-agency comparison in the Crucible app.
Data: SBIR.gov award records + USAspending.gov prime contracts, matched by recipient name. Follow-on dollars are association, not causation — they show where this firm's later federal prime-contract dollars landed, not that SBIR work caused them. Methodology